Trials / Conditions / Rotavirus Infections

Rotavirus Infections

26 registered clinical trials studyying Rotavirus Infections.

Status	Trial	Sponsor	Phase
Active Not Recruiting	CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults NCT06962904	Centers for Disease Control and Prevention	Phase 1
Completed	CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults NCT06485258	Centers for Disease Control and Prevention	Phase 1
Unknown	Phase II Clinical Trial of the Inactivated Rotavirus Vaccine NCT06080906	Institute of Medical Biology, Chinese Academy of Medical Sciences	Phase 2
Active Not Recruiting	Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Todd NCT05621655	MAXVAX Biotechnology Limited Liability Company	Phase 2
Unknown	A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region NCT05212935	Federico II University	—
Completed	Evaluation of an Infant Immunization Encouragement Program in Nigeria NCT03870061	GiveWell	N/A
Completed	Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Fr NCT05037435	Limited Liability Company Pharm Aid	Phase 3
Completed	A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine NCT03483116	Murdoch Childrens Research Institute	Phase 2
Unknown	Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in V NCT03367559	Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products	Phase 3
Completed	SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance NCT03313128	London School of Hygiene and Tropical Medicine	—
Completed	Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study NCT02542462	Children's Hospital Medical Center, Cincinnati	Phase 4
Completed	The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses NCT02538211	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	N/A
Completed	Does the Fecal Microbiome Influence Rotarix Immunogenicity NCT02220439	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	—
Completed	Vaccine Effectiveness of RV1 in a Naïve Population NCT01467037	McGill University Health Centre/Research Institute of the McGill University Health Centre	—
Withdrawn	Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy India NCT00757926	Shantha Biotechnics Limited	Phase 1 / Phase 2
Completed	Rotavirus Vaccine Produced by Butantan Institute NCT00981669	Butantan Institute	Phase 1
Terminated	ROTATEQ™ Post-Marketing Surveillance in the Philippines NCT01357174	Merck Sharp & Dohme LLC	—
Unknown	Surveillance of Hospitalizations Due to Rotavirus Infections Among Children From Israel NCT00484952	Hillel Yaffe Medical Center	—
Completed	RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016) NCT00443846	Merck Sharp & Dohme LLC	Phase 3
Unknown	Surveillance of Rotavirus Gastroenteritis in Children <5 Years NCT01363726	Soroka University Medical Center	—
Completed	Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED NCT00130832	Merck Sharp & Dohme LLC	Phase 3
Completed	Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in NCT00280111	Society for Applied Studies	Phase 1
Completed	Consistency Lots Vaccine Study (V260-009) NCT00092456	Merck Sharp & Dohme LLC	Phase 3
Completed	Dose Confirmation Efficacy Study (V260-007) NCT00092443	Merck Sharp & Dohme LLC	Phase 3
Completed	To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV NCT00346892	GlaxoSmithKline	Phase 2
Completed	Rotavirus Efficacy and Safety Trial (REST)(V260-006) NCT00090233	Merck Sharp & Dohme LLC	Phase 3